About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Pyrrolidines, Not the Usual Way | Main | Crowdfunding Research »

May 13, 2013

Astellas Closing the OSI and Perseid Sites?

Email This Entry

Posted by Derek

I've heard this morning that Astellas is closing the OSI site in Farmingdale, NY, and the Perseid Therapeutics site in Redwood City, CA. More details as I hear them (and check the comments section; people with more direct knowledge may be showing up in there).

Comments (12) + TrackBacks (0) | Category: Business and Markets


1. Bhip on May 13, 2013 12:41 PM writes...

Also announced on Long Island news site

shuttering facilities in Farmingdale, Redwood City, Calif., and Skokie, Ill.

Permalink to Comment

2. Anonymous on May 13, 2013 1:52 PM writes...

Geez... I guess with the currency exchange, Japan no longer has a the yen for us....

Permalink to Comment

3. West Coast Chemist on May 13, 2013 9:12 PM writes...

...impenetrable human resources communication on the corporate website:

Permalink to Comment

4. Nigel Tufnel on May 14, 2013 1:11 AM writes...

What's at Skokie? Looks like R&D?

Permalink to Comment

5. Angela on May 14, 2013 4:10 AM writes...

Too Bad

Permalink to Comment

6. Paul on May 14, 2013 12:17 PM writes...

I was a scientist at Perseid. It was grim yesterday. They announced at 10:00 and gave us 60 min to pack and clear the building.

Permalink to Comment

7. John on May 14, 2013 2:08 PM writes...

Paul, Really sorry to hear that.

Permalink to Comment

8. Ex-OSI on May 14, 2013 4:12 PM writes...

#6. Yup, same at OSI.
A sudden 10am town hall meeting, then 60 min to pack up and leave, all exits being guarded by thugs in cheap polyester suits, and being searched at the exit. Should have used the fire pull for some fun...oh well. Truly a "Changing Tomorrow" event (FYI - changing tomorrow is Astellas' tag line)

Permalink to Comment

9. researchfella on May 14, 2013 11:45 PM writes...

Very sad, but I guess it wasn't too much of a surprise. The CSO and some senior R&D management moved to other jobs a month or two ago, according to LinkedIn.

Permalink to Comment

10. RIPOSI on May 15, 2013 11:04 AM writes...

#8, wasn't it a great experience? To be fair, one of the guards at the door commented to me how awful it all was.

"Changing Tomorrow"... yeah...

Permalink to Comment

11. CanD on May 15, 2013 9:51 PM writes...

Skokie location is a research consisting of immunology, cns and analytical for clinical. Cns and analytical to remain innulogy is gone. It was very grim

Permalink to Comment

12. SCM on May 30, 2013 7:52 AM writes...

@6: Very sorry man. I work in Astellas in EU and feeling very bad for the way the japs handled the situation...

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry